secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bluejay Diagnostics, Inc. (BJDX)
CIK:        0001704287
Form:       8-K
Filed at:   2025-04-09T23:59:59+00:00
Accession:  0001213900-25-030312
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bluejay Diagnostics raises ~$3.7M via warrant inducement; existing holders exercise at reduced price
--------------------------------------------------------------------------------

- Entered inducement agreements to exercise 1,085,106 Class C warrants at reduced exercise price of $3.42/share (down from $16.30).
- Gross proceeds ~$3.7M; issued new Class E warrants for 1,085,106 shares exercisable at $3.42 through April 8, 2030.
- Issued 682,203 common shares at closing; pre-funded warrants for 402,903 shares to avoid beneficial ownership limits.
- Paid Aegis Capital Corp. $385,000 financial advisory fee; transaction closed April 8, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1704287/000121390025030312/0001213900-25-030312-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1704287/000121390025030312/ea0237671-8k_bluejay.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-030312

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer